These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4429965)

  • 1. Effect of route of administration and effusions on methotrexate pharmacokinetics.
    Wan SH; Huffman DH; Azarnoff DL; Stephens R; Hoogstraten B
    Cancer Res; 1974 Dec; 34(12):3487-91. PubMed ID: 4429965
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of malignant effusions on methotrexate disposition.
    Li J; Gwilt P
    Cancer Chemother Pharmacol; 2002 Nov; 50(5):373-82. PubMed ID: 12439595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pleural effusion on high-dose methotrexate kinetics.
    Evans WE; Pratt CB
    Clin Pharmacol Ther; 1978 Jan; 23(1):68-72. PubMed ID: 618710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cefoxitin in patients with pleural effusion on a multiple dosage regimen.
    Garcia MJ; Otero MJ; Barrueco M; Dominguez-Gil A
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):300-3. PubMed ID: 6746153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of methotrexate.
    Huffman DH; Wan SH; Azarnoff DL; Hogstraten B
    Clin Pharmacol Ther; 1973; 14(4):572-9. PubMed ID: 4723265
    [No Abstract]   [Full Text] [Related]  

  • 6. The kinetics of cefuroxime in ascitic and pleural fluid.
    Lechi A; Arosio E; Xerri L; Mengoli C; Montesi G; Ghidini O
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):493-6. PubMed ID: 6815108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effective levels of cyclophosphamide and metabolites in pleural effusions during intravenous therapy (author's transl)].
    Wagner T; Heydrich D
    Arzneimittelforschung; 1982; 32(5):566-8. PubMed ID: 7201835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors.
    Pratt CB; Roberts D; Shanks EC; Warmath EL
    Cancer Res; 1974 Dec; 34(12):3326-31. PubMed ID: 4547680
    [No Abstract]   [Full Text] [Related]  

  • 9. [Deviations in glycoprotein contents in malignant ascitic fluid and pleural effusions].
    Ohtani H
    Rinsho Byori; 1983 Sep; 31(9):940-4. PubMed ID: 6663770
    [No Abstract]   [Full Text] [Related]  

  • 10. Vulvar carcinoma treated successfully.
    Chamoun CD; Downing V; Huseby RA
    Rocky Mt Med J; 1974 Feb; 71(2):89-93. PubMed ID: 4811717
    [No Abstract]   [Full Text] [Related]  

  • 11. A study of the distribution of methotrexate in human tissues and tumors.
    Anderson LL; Collins GJ; Ojima Y; Sullivan RD
    Cancer Res; 1970 May; 30(5):1344-8. PubMed ID: 5426936
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytological studies on exfoliated cells in serous effusions.
    Affandi MZ; Sirsat SM
    Indian J Cancer; 1970 Dec; 7(4):257-73. PubMed ID: 4996414
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacokinetics of intravenous methotrexate in children with neoplasms of the hematopoietic system].
    Hermann T; Skibińska L; Szwarc E; Michalewska D
    Pol Tyg Lek; 1984 May; 39(21):713-6. PubMed ID: 6592554
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Altered plasma pharmacokinetics of methotrexate administered intrathecally.
    Jacobs SA; Bleyer WA; Chabner BA; Johns DG
    Lancet; 1975 Feb; 1(7904):465-6. PubMed ID: 48664
    [No Abstract]   [Full Text] [Related]  

  • 15. Uptake and distribution of 3 H-methotrexate by the murine ependymoblastoma.
    Levin VA; Clancy TP; Ausman JI; Rall DP
    J Natl Cancer Inst; 1972 Apr; 48(4):875-83. PubMed ID: 4537157
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of intravenous and oral high-dose methotrexate in treatment of solid tumours.
    Christophidis N; Vajda FJ; Lucas I; Moon WJ; Louis WJ
    Br Med J; 1979 Feb; 1(6159):298-300. PubMed ID: 421088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of c-Ha-ras oncogene expression in pleural and peritoneal smear effusions by in situ hybridization.
    Athanassiadou PP; Veneti SZ; Kyrkou KA; Athanassiades PH
    Cancer Detect Prev; 1993; 17(6):585-90. PubMed ID: 8275510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of immunoperoxidase staining in serous effusions.
    Sarker AB; Hoshida Y; Nose S
    Bangladesh Med Res Counc Bull; 1993 Aug; 19(2):33-8. PubMed ID: 8161332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in tight junction of the cancer cells from human effusions.
    Woyke S; Czerniak B; Lukaszyk I
    Acta Med Pol; 1979; 20(4):475-6. PubMed ID: 546123
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of ticarcillin in the horse after intravenous and intramuscular administration.
    Sweeney CR; Soma LR; Beech J; Reef V; Simmons R
    Am J Vet Res; 1984 May; 45(5):1000-2. PubMed ID: 6732002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.